WHO ICTRP trial

A drug-drug interaction clinical study to investigate the effects of…

KCT0009124 · Clinical Research Information Service (CRIS) · Not Recruiting

Key facts

Trial ID KCT0009124
Public title A drug-drug interaction clinical study to investigate the effects of Bojungikgi-tang and Pingwei-san on the pharmacokinetics of Metformin, Dapagliflozin and Sitagliptin tablets in healthy male volunteers
Scientific title An open-label, two-sequence, three-period, randomized crossover clinical study to investigate the effects of Bojungikgi-tang and Pingwei-san on the pharmacokinetics of Metformin, Dapagliflozin and Sitagliptin tablets in healthy male volunteers
Primary sponsor Kyung Hee University Hospital
Registry Clinical Research Information Service (CRIS)
Recruitment status Not Recruiting
Study type Interventional Study
Phase Not applicable
Countries Korea, Republic of
Conditions Not Applicable
Interventions Drug : This clinical trial is to compare and evaluate the effects of bojungikgitang and pyeongwisan on pharmacokinetic properties in three types of diabetes drugs and the effects of bojungikgitang and pyeongwisan on pharmacokinetic…
Registration date Jan 19, 2024
Target size 16
Registry page cris.nih.go.kr

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations